Hester Biosciences consolidated net profit rises 9.27% in the March 2024 quarter

Sales rise 17.77% to Rs 79.26 crore

Net profit of Hester Biosciences rose 9.27% to Rs 4.95 crore in the quarter ended March 2024 as against Rs 4.53 crore during the previous quarter ended March 2023. Sales rose 17.77% to Rs 79.26 crore in the quarter ended March 2024 as against Rs 67.30 crore during the previous quarter ended March 2023.

For the full year,net profit declined 29.06% to Rs 18.89 crore in the year ended March 2024 as against Rs 26.63 crore during the previous year ended March 2023. Sales rose 14.45% to Rs 304.55 crore in the year ended March 2024 as against Rs 266.09 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales79.2667.30 18 304.55266.09 14 OPM %20.0917.34 -17.6219.02 - PBDT13.6113.79 -1 49.1360.85 -19 PBT9.878.42 17 31.9540.15 -20 NP4.954.53 9 18.8926.63 -29

Powered by Capital Market - Live News